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Abstract: We developed a (three-dimensional) 3D scaffold, we named HY-FIB, incorporating
a force-transmission band of braided hyaluronate embedded in a cell localizing fibrin hydrogel
and poly-lactic-co-glycolic acid (PLGA) nanocarriers as transient components for growth factor controlled
delivery. The tenogenic supporting capacity of HY-FIB on human-Bone Marrow Mesenchymal Stem
Cells (hBM-MSCs) was explored under static conditions and under bioreactor-induced cyclic strain
conditions. HY-FIB elasticity enabled to deliver a mean shear stress of 0.09 Pa for 4 h/day. Tendon
and cytokine marker expression by hBM-MSCs were studied. Results: hBM-MSCs embedded in HY-FIB
and subjected to mechanical stimulation, resulted in a typical tenogenic phenotype, as indicated by
type 1 Collagen fiber immunofluorescence. RT-qPCR showed an increase of type 1 Collagen, scleraxis,
and decorin gene expression (3-fold, 1600-fold, and 3-fold, respectively, at day 11) in dynamic conditions.
Cells also showed pro-inflammatory (IL-6, TNF, IL-12A, IL-1β) and anti-inflammatory (IL-10, TGF-β1)
cytokine gene expressions, with a significant increase of anti-inflammatory cytokines in dynamic
conditions (IL-10 and TGF-β1 300-fold and 4-fold, respectively, at day 11). Mechanical signaling,
conveyed by HY-FIB to hBM-MSCs, promoted tenogenic gene markers expression and a pro-repair
cytokine balance. The results provide strong evidence in support of the HY-FIB system and its interaction
with cells and its potential for use as a predictive in vitro model.
Keywords: hBM-MSCs; cytokines; tenogenic markers; cyclic strain; 3D microenvironment; PLGA
carriers; bioreactor
1. Introduction
Tissue engineering strategies for tendon healing and regeneration are designed to improve existing
therapies or provide new treatment possibilities. Three-dimensional (3D) bioengineered systems have
the potential to promote our understanding of the physiopathology of tendinopathy and the role
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of stem cells in tendon regeneration. In this sense, 3D scaffold design and fabrication coupled to
specific bioreactor arrangements could develop highly predictive 3D in vitro culture and differentiation
systems to explore cell behaviors in response to defined external biochemical and mechanical stimuli [1].
The 3D scaffold provides a model of fidelity via its provision of a microenvironment with defined
stiffness and elastic modulus as well as the necessary surfaces for cell attachment [2–4].
Detailed understanding of cell behavior when incorporated into specific biomaterials allows to
develop designs with specific functionalization. These functionalization may, for instance, stimulate
local stem cells, attract specific circulating nucleated blood cells, such as macrophages, and induce their
polarization into M2 phenotype to accelerate tissue regeneration and healing following the biomaterials
in vivo implantation [5]. For example, human Mesenchymal Stem Cells (hMSCs) are largely used in tissue
engineering strategies, and their immune-modulatory activity in the development of tendon pathologies
have been explored, but the precise mechanisms involved remain undetermined [6–10]. Neutrophils
and macrophages infiltrate injured tendons, potentially interacting with MSCs and stimulating cytokine
release at the site of repair and promoting degradation of the extracellular matrix (ECM), inflammation,
apoptosis, and, in the later stages of acute tendon healing, they release anti-inflammatory cytokines to
alleviate inflammation and promote tendon remodeling [11–13].
Among the biomaterials described for tendon tissue engineering [14], a promising emerging
strategy is the use of a complex biomimetic matrix with a hydrogel component and extracellular matrix
mimicking properties [15,16]. Tenocyte precursors can be harvested from different sources, including
periosteum [17,18], bone marrow [19–21], tendon [21,22], and adipose tissue [21,23]. To overcome
the intrinsic poor mechanical properties of the hydrogel, they can be merged with more force
resistant biopolymers. Cells and biomaterials alone are not sufficient to achieve optimal levels
of differentiation and matrix organization. Mechanical stimulation has a key role in tenogenic
differentiation induction [19]. Scaffolds are therefore required to display an appropriate elastic
behavior to deliver strain [24] or compression [25] inputs. Strain is a tenogenic differentiation
signal [26–29], and several bioreactors have been used to impart tenogenic mechanical stimuli to cells
in culture [19,30–35]. For example, Rinoldi et al. designed and fabricated 3D multilayered composite
scaffolds, where an electrospun nanofibrous substrate was coated with a thin layer of GelMA-alginate
composite hydrogel carrying MSCs. MSCs were subsequently differentiated by the addition of bone
morphogenetic protein 12 (BMP-12) and, to mimic the natural function of tendons, the scaffolds
were mechanically stimulated using a custom-built bioreactor [34]. Grier et al. described an aligned
collagen-glycosaminoglycan scaffold able to enhance tenogenic differentiation of MSCs via cyclic
tensile strain within a bioreactor, in the absence of growth factor supplementation [36]. Another
protocol, proposed by Youngstrom et al., promoted tenogenic differentiation of MSCs cultivated on
decellularized tendon scaffolds with the application of 3% cyclic strain for one hour per day for 11
days [31]. Additionally, several growth factors and other small molecules can stimulate transcriptional
activation of genes involved in tenogenic differentiation [15,37,38]. Growth Differentiation Factor 5
(GDF-5), for instance, induces the expression of genes linked to the neo-tendon phenotype [39–41].
Tendinopathies associated with physical activity and age-related degeneration are a major medical
issue [23], and recent healing and regeneration studies include the use of human Bone Marrow
Mesenchymal Stem Cells (hBM-MSCs) [42–44]. hBM-MSCs are a multipotent population present
in bone marrow that can be readily differentiated in vitro [45,46] into cells of three mesodermal
lineages, namely adipocytes, chondrocytes and osteoblasts under appropriate conditions [47–50].
MSCs-based therapies include direct transplantation of MSCs populations, growth factor-loaded
scaffolds for local MSCs recruitment or implantation of scaffolds containing in vitro culture-expanded
MSCs populations [51,52].
We previously described an engineered multiphase three-dimensional (3D) scaffold as an in vitro
model for tendon regeneration studies. The multiphase 3D construct was totally absorbable
and consisted of a braided hyaluronate elastic band merged with a fibrin hydrogel containing
hBM-MSCs and poly-lactic-co-glycolic acid nano-carriers (PLGA-NCs) themselves loaded with human
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Growth Differentiation Factor 5 (hGDF-5) [53]. In that work, the PLGA nano-carriers were transient
scaffold components to ensure sustained and controlled delivery of hGDF-5 with benefits beyond
those associated with standard culture medium supplementation [53,54]. The study reported an early
tenogenic commitment of hBM-MSCs after three days of cultivation under dynamic conditions.
In the present study, we describe the use of the same scaffold (named HY-FIB here) to investigate
the effect of the 3D environment on hBM-MSCs for 11 days with or without mechanical stimulation
and in the absence of any specific biochemical differentiation signal. HY-FIB was assembled with
hBM-MSCs as previously described [53] including PLGA-NCs stratified within the 3D fibrin structure.
Importantly, the PLGA-NCs carried an inactive form of human Growth Differentiation Factor 5
(ihGDF-5) enabling the overall 3D scaffold structure to be safely evaluated with or without mechanical
input. Gene expression of type 1 Collagen, decorin, scleraxis, and tenomodulin were considered; type 3
collagen was also monitored, as negative control. Histology and quantitative immunofluorescence were
used to monitor cell behavior and their interaction with the synthetic extracellular matrix. Moreover,
to understand whether HY-FIB microenvironment configuration would stimulate any cell inflammation
responses, the cells expression of cytokine markers was also monitored, including pro-inflammatory
cytokines and anti-inflammatory ones. The results provide strong evidence that HY-FIB environment
plus mechanical signaling, promoted tenogenic markers expression, collagen production and better
pro-repair cytokine balance by hBM-MSCs.
2. Materials and Methods
2.1. hBM-MSCs Isolation and Harvesting
Human bone marrow mesenchymal stem cells (hBM-MSCs) were obtained from the bone marrow
of three independent healthy donors (age 36, 38, 44 years). The donors gave written informed consent
in accordance with the Declaration of Helsinki to the use of their filter residual bone marrow aspirate
for research purposes, with approval from the University Hospital of San Giovanni di Dio e Ruggi
d’Aragona (Salerno, IT). Review Board authorization number: (24988 achieved on April 9, 2015).
Briefly, total bone marrow aspirate was directly seeded at a concentration of 50,000 total nucleated
cells/cm2 in T75 plastic flask in Minimum Essential Medium Alpha (α-MEM) supplemented with
1% GlutagroTM, 10% Fetal Bovine Serum (FBS), and 1% Pen/Strep and incubated at 37 ◦C in 5% CO2
atmosphere and 95% relative humidity [55]. After 72h, non-adherent cells were removed by medium
change, and the adherent cells were further fed twice a week with new medium. On day 14, colonies
of adherent hBM-MSCs were detached and re-seeded at 4000 cells/cm2 in the same culture conditions.
Once the cell cultures reached 70–80% confluence, cells were detached using 0.05% trypsin-0.53mM
EDTA and washed with PBS 1× (Corning Cellgro, Manassas, VA, USA), counted using Trypan Blue
(Sigma-Aldrich, Milan, IT) and subcultured at a concentration of 4 × 103 cells/cm2. Flow Cytometry
analysis was performed on hBM-MSCs obtained at Passage 1 examining levels of CD90, CD105, CD73
CD14, CD34, CD45, and HLA-DR expression (Miltenyi Biotec, DE).
2.2. ihGDF-5 Effect on hBM-MSCs
These sets of experiments were performed to assure the absence of any effect of inactivated human
GDF-5 (ihGDF-5, Cloud-Clone Corp., USA) on both tenogenic markers stimulation and cytokines
expression by hBM-MSCs. Cells were seeded on coverslips in 12 well plates at a concentration of
4 × 103 cells/cm2. Once the cultures reached 60% confluence, cells were treated with either 1.6 ng/mL
or 100 ng/mL of ihGDF-5. Cells were fed twice a week with new medium and fresh ihGDF-5
supplementation for up to 16 days. Untreated cells for matched time-points studied were used for
control purposes. Passage 3 cells were seeded in the 3D environment (~8 × 105 cells/mL) and were fed
twice a week with new medium, without any growth factor added.
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PLGA carriers were not tested because they cannot be supplemented to the cells planar monolayer
culture, indeed, in static conditions their sedimentation on cells reduced oxygen exchange and prevented
cells survival (data not shown).
2.3. Immunofluorescence and Immunohistochemical Assays
Cells were fixed with 3.7% formaldehyde for 30 min at room temperature (RT) followed by
permeabilization with 0.1% Triton X-100 for 5 min and blocking with 1% Bovine Serum Albumine (BSA)
for 1h. For type 1 and type 3 Collagen staining, cells were incubated overnight at 4 ◦C with a mouse
monoclonal anti-type 1 Collagen antibody (1:100, Sigma-Aldrich) and a rabbit polyclonal anti-type
3 Collagen antibody (1:100, Santa Cruz Biotechnology). Following incubation with the primary
antibody, cells were incubated for 1h at RT with the DyLight 649 anti-mouse IgG (1:500, BioLegend,
CA) and the Alexa FluorTM 488 goat anti-rabbit IgG (1:500; Thermo Fisher Scientific, USA). Cell nuclei
were stained with DAPI solution (1:1000) for 5 min. Images acquisition was at 20× magnification on
a fluorescent microscope (Eclipse Ti-E Inverted Microscope; NIKON Instruments Inc., USA).
For 3D scaffold immunohistochemical analysis, slices were permeabilized with 0.1% Triton X-100
for 5 min, and non-specific staining blocked with 1% BSA for 1h at RT. For type 1 Collagen staining,
slices were incubated overnight at 4 ◦C with a rabbit polyclonal anti-type 1 Collagen antibody (1:200,
AbCam). Following incubation with the primary antibody, slices were incubated for 1h at RT with
Alexa FluorTM 488 goat anti-rabbit IgG (1:400, Thermo Fisher Scientific, USA) antibody. Subsequently,
cell nuclei were stained with DAPI solution (1:1000) and incubated for 5 min. Images were acquired as
described above. Image quantification was performed using image analysis software (ImageJ, National
Institutes of Health, USA) [56,57] by measuring the red and green areas where type 1 and type 3
collagen, respectively, are expressed. A minimum of 10 image fields was used for the image analysis
at each time point. Signal intensity at each time point was normalized by the cell number (e.g., by
amount of cell nuclei revealed by DAPI staining).
Sirius red staining was performed using the Picrosirius Red Stain Kit (Polysciences, Inc., USA).
Sections of 15 µm of thickness were stained in hematoxylin for 8 min, then washed in water for 2
min. The sections were dipped into phosphomolybdic acid for 2 min, then washed in water for 2 m.
Then they were dipped into Picrosirius Red F3BA Stain for 60 min and dipped into HCl 0.1M solution
for 2 min. The sections were dehydrated in increasing ethanol gradient solutions (70–75–95–100%)
and finally dipped into xylene for 5 min. Eukitt medium was used to mount the samples.
2.4. RNA Isolation and Gene Expression Profile by Quantitative Reverse Transcription PCR (RT-qPCR)
Total RNA was extracted from hBM-MSCs seeded into the 3D construct of each experimental group
using QIAzol® Lysis Reagent (Qiagen, DE), chloroform (Sigma-Aldrich, Milan, IT) and the RNeasy Mini
Kit (Qiagen, DE). For each sample, 300 ng of total RNA was reverse-transcribed using the iScriptTM
cDNA synthesis kit (Bio-Rad, Milan, IT). Relative gene expression analysis was performed in
a LightCycler® 480 Instrument (Roche, IT), using the SsoAdvancedTM Universal SYBR® Green
Supermix (Bio-Rad) with the validated primers for COL1A1, COL3A1, DCN, IL-1β, IL-6, IL-10, IL-12A,
SCX-A, TGF-β1, TNF, and TNMD (Bio-Rad), and following MIQE guidelines [58]. Amplification
was performed in a 10 µL final volume, including 2 ng of complementary DNA (cDNA) as template.
Specificity of the formed products was addressed via melting curve analysis. Triplicate experiments
were performed for each condition explored, and data were normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression (reference gene), applying the geNorm method [59] to calculate
reference gene stability between the different conditions (calculated with CFX Manager software;
M <0.5). Fold changes in gene expression were determined by the 2−∆∆Cp method, and are presented
as relative levels versus hBM-MSCs just loaded within the HY-FIB system.
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2.5. PLGA-NCs Fabrication, Size, Morphology, and ihGDF-5 Release Profile
PLGA nano-carriers (PLGA-NCs) were obtained using Supercritical Emulsion Extraction (SEE)
technology enabling rapid polymer NCs production from multiple emulsions via dense gas extraction
of the oily phase organic solvent utilizing a countercurrent packed tower operating in continuous
mode [60]. In detail, ihGDF-5 (Cloud-Clone Corp., USA) was dissolved into 1% (w/v) human serum
albumin (hSA; Sigma-Aldrich, Milan, IT) containing 0.06% polyvinyl alcohol (PVA). Human serum
albumin (hSA) was included as an ihGDF-5 stabilizer. This solution was added to the oily phase
formed in an Ethyl Acetate (EA, purity 99.9%) and PLGA (RG 504H, 38,000–54,000 kDa, Evonik, DE)
at 5% (w/w) solution. All emulsions were processed immediately after their preparation.
SEE technology operative pressure and temperature conditions in the high-pressure column were
set at 8 MPa and 38 ◦C, respectively, with a dense gas flow of Carbon Dioxide (CO2) set at 1.4 kg/h with
Liquid/Gas ratio of 0.1 (w/w) [61]. Carrier suspensions were collected at the bottom of the extraction
column, washed, and lyophilized. Each run allowed the recovery of 98% of the loaded biopolymer.
Empty and loaded NCs were produced using the same process conditions.
Carrier particle size distributions (PSDs) were measured using a laser granulometer (mod.
Mastersizer S; Malvern Instruments Ltd., Worcestershire, UK), based on dynamic light scattering
(DLS). Sizes are expressed as volume mean size (MS) with standard deviation (SD) in nanometers
(nm). The shape and morphology of the PLGA-NCs were investigated by field emission-scanning
electron microscopy (FE-SEM; mod. LEO 1525; Carl Zeiss, Oberkochen, D). Samples were placed on
a double-sided adhesive carbon tape previously glued to an aluminum stub and coated with a gold
film (250 A thickness) using a sputter coater (mod.108 A; Agar Scientific, Stansted, UK).
ihGDF-5 release profile was monitored in vitro from 20(±0.3) mg of carriers suspended in 1mL of
α-MEM, placed in an incubator at 37 ◦C, and stirred continuously at 1× g. Every 24 h, samples were
centrifuged at 160× g for 10 min and the supernatant completely removed and replaced with fresh
media to maintain sink conditions. Released ihGDF-5 concentrations from collected samples were then
measured with an Enzyme Linked Immunosorbent Assay (ELISA, Cloud-Clone Corp., USA). Release
experiments were performed in triplicate (n = 3), and the curve describing the mean profile calculated
as ng/g (protein released/PLGA-NCs) versus time.
2.6. HY-FIB Preparation and Characterization
For each sample, a mixture of 50 mg/mL fibrinogen from human plasma (Sigma-Aldrich, Milan, IT),
15,600 U/mL aprotinin (Sigma-Aldrich, Milan, IT), and α-MEM (Corning, NY, USA) supplemented with
10% FBS (referred to as growing media, GM) was added at a 1:1:1 ratio to 100 mg of PLGA-NCs (ihGDF-5
loading: 350 ng/g) and, then, to an average of 8 × 105 cells. A homogeneous cells/PLGA-NCs/fibrinogen
suspension was then embedded into a mold (30 × 20 × 4.5 mm) where the braided band had been
previously positioned. Free ends were left to enable HY-FIB fixing into the bioreactor. Upon addition of
100 U/mL thrombin (Sigma-Aldrich, Milan, IT), the mold was placed in a 37 ◦C humidified incubator for
30 min to allow fibrin polymerization. When the hydrogel was formed, the band was entrapped inside
a uniformly distributed hydrogel. The construct was then transferred from the mold to either a standard
polystyrene culture plate or to the bioreactor culture chamber, each containing 30 mL of the culture
media, and placed in an incubator at 37 ◦C in a 5% CO2 atmosphere and 95% relative humidity.
HY-FIB morphology was observed by field emission-scanning electron microscopy (FE-SEM;
mod. LEO 1525; Carl Zeiss, Oberkochen, Germany). Samples were fixed in 4% PFA (4 ◦C, overnight)
and then dehydrated by multiple passages across ethanol:water solutions (10 min each) with increasing
concentrations of ethanol (10%, 20%, 30%, 50%, 70%, 90%), ending in a 100% dehydrating liquid
(3 changes, 10 min each).
Samples were then lyophilized in a Critical Point Dryer (mod. K850 Emitech, Assing, Rome IT),
placed on a double-sided adhesive carbon tape previously glued to an aluminum stub and coated
with a gold film (250 A thickness) using a sputter coater (mod. 108 A; Agar Scientific, Stansted,
United Kingdom) before observation.
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HY-FIB mechanical characterization was performed according to the ASTM 1708 by a dynamometer
(CMT 6000 SANS, Shenzen, China) equipped with a 1 kN load cell. The sample was conditioned
in Dulbecco’s Modified Essential Medium (DMEM) for 1 h, and then shaped to obtain a specimen
with gauge length (Lo) of 22 mm and width (W) of 5 mm. Sample thickness (S) was measured with
a thickness gauge brand at three different averaged points. Monoaxial deformation was applied to
the sample at a speed of 10 mm/min, and force (F) and elongation (L) during traction were recorded.
The elastic modulus and ultimate tensile strength (both expressed in MPa) were calculated from
the stress/strain plot. For the immuno-histochemical analysis, at different time points, a portion of
HY-FIB was fixed in 4% PFA (4 ◦C, overnight), cryo-protected in 30% sucrose overnight, mounted in
OCT embedding compound, frozen at−20◦C and then cut in slices of 10µm of thickness using a cryostat.
The remaining portion of HY-FIB was placed in QIAzol® Lysis Reagent for total RNA extraction.
2.7. Dynamic Culture
HY-FIB was clamped at both free ends, one motionless and one sliding (operated by a linear
motor actuator) arm, into the bioreactor system culture chamber, described in detail elsewhere [23].
A maximal load, set by pre-tensioning, was relaxed to a minimum value cycling at a pre-determined
frequency. In addition, continuous feedback signals provided by strain gauges located onto the fixed
arm, allowed the maintenance of a defined load on the scaffold in response to physical system
modifications, by automatic adjustment of the pre-tensioning position.
2.8. Finite Element Modeling
Finite Element Modeling (FEM) was implemented by using COMSOL Multiphysics Software
(rel. 5.3a®) to assess the stress distribution into 3D constructs when a 10% mechanical cyclic strain
stimulus is applied. All components were obtained using primitive geometries and Boolean operations.
Linear elasticity equations were set as boundary conditions for the scaffold. A sensitivity study
of the mesh obtained the most computationally efficient solution. The specific parameters used
in the model are listed in Table 1. The simulation considered only the stress within the fibrin 3D
environment neglecting any further contribution of the band, cells and PLGA-NCs.
Table 1. Finite Element Modeling (FEM) parameters used.
Parameters Value Unit
Young’s modulus 1 4.56 MPa
Poisson ratio 2 0.25 -
Density 1050 Kg/m3
1 HY-FIB Young Modulus was measured experimentally [53] 2 Poisson ratio value was taken in the literature [62].
2.9. Statistical Analysis
Statistical analysis was performed using GraphPad Prism software (6.0 for Windows).
Data obtained from multiple experiments are expressed as mean+/−SD and analyzed for statistical
significance using ANOVA test, for independent groups. Differences were considered statistically
significant when p ≤ 0.05 [63].
3. Results
3.1. hBM-MSCs Cultivation in 2D Environment
hBM-MSCs were cultivated in a two-dimensional (2D) monolayer environment with medium
supplemented with either 1.6 ng/mL or 100 ng/mL of inactive human Growth Differentiation Factor 5
(ihGDF-5) for up to 16 days. These two concentration conditions (two order of magnitude of difference)
were chosen to ascertain absence of any effect of the inactive hGDF-5 form on cells expression of
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tenogenic markers (COL3A1, COL1A1, DCN, SCX-A and TNMD) and of cytokines (pro-inflammatory:
IL-6, TNF, IL-12A, IL-1β; anti-inflammatory: IL-10, TGF-β1) by RT-qPCR (see Figure 1a–d).
Figure 1. Gene expression profiles for tenogenic markers and pro-inflammatory and anti-inflammatory
cytokines by hBM-MSCs treated with 1.6 ng/mL (a,c) and 100 ng/mL (b,d) of ihGDF-5 in monolayer
2D culture up to 16 days. mRNA levels of COL1A1, DCN, SCX-A, and TNMD were considered
as tenogenic markers and COL3A1 selected as negative ones; pro-inflammatory (IL-6, TNF, IL-12A
and IL-1β) and anti-inflammatory (IL-10 and TGF-β1) cytokines were monitored. ihGDF-5 not had
significant impact on genes expression, especially at the lower concentration tested. Untreated cells for
matched time-points were used as control. * ≤ 0.05; ** <0.01; *** <0.005; **** <0.001 N = 3 (biological
replicates); n = 3 (technical replicates).
Transient and slight, though significant, upregulation of COL3A1 (0.4-fold), DCN (0.2-fold),
and COL1A1 (0.5-fold) was observed at Day 1 in cultures supplemented with 100 ng/mL ihGDF-5
(Figure 1b). The reduced dose of 1.6 ng/mL induced low-level transient expression at Day 1 for only
COL3A1 (0.3-fold) and DCN (0.2-fold) only (Figure 1a). No significant upregulation was noted for
TNF, IL-12A, IL-1β, IL-10, or TGFβ at any time point or ihGDF-5 concentration tested (Figure 1c,d).
Compared to controls, IL-6 displayed significant levels of elevation at Days 8 (0.8-fold) and 16
(0.5-fold) with 100 ng/mL ihGDF-5 (Figure 1d). Types 1 and 3 Collagen expression levels were
monitored by immunofluorescence during the 16 day culture period, as illustrated in Figure 2a,b.
Immunofluorescence quantitative data by image analysis were congruent with RT-qPCR outputs
when 1.6 ng/mL ihGDF-5 was supplemented, in this case, both proteins signals were not significantly
elevated, compared to untreated cells (see Figure 2c).
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Figure 2. IF and quantitative-IF assays of type 1 Collagen (COL1A1) and type 3 Collagen (COL3A1)
monitored along hBM-MSCs treatment with 1.6 ng/ and 100 ng/mL of ihGDF-5 for 16 days. Type 1
collagen was stained in red; type 3 collagen was stained in green; cell nuclei highlighted with DAPI in
blue (a,b). Quantitative signal detection was performed via ImageJ software (c). A slight up-regulation
of COL1A1 was observed when hBM-MSC were in routine culture for 16 days. Color intensity in each
time point was normalized by the cell number. * ≤0.05; * *<0.01; *** <0.005; **** <0.001. n = 10 (image
fields for each time point).
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Quantitative image analysis displayed COL1A1 signal increase (1 fold) at Day 16 only with
100 ng/mL ihGDF-5 supplementation. This last data is in contrast with gene expression ones. COL1A1
and COL3A1 are the major components of the extracellular matrix in connective tissues, and their
slight up-regulations was reported when hBM-MSC were in routine culture for 16 days [64]. However,
in our case, ihGDF-5 seemed not to impact on their production, especially at the lower concentration
tested. This preliminary information is important to confirm the inactivity of the biochemical input in
regards to the gene expression and proteins that will be monitored in the 3D experiments.
3.2. PLGA-NCs Fabrication and ihGDF-5 Controlled Deliver
Poly-lactic-co-glycolic-acid nano-carriers (PLGA-NCs) displayed a spherical morphology with
a mean size of 230 ± 80 nm (Figure 3a). PLGA-NCs had an ihGDF-5 loading of 350 ng/g and provided
a daily released peptide mean concentration of 1.6 ng/mL/day (Figure 3b), when an amount of 100 mg
were inserted within HY-FIB over 11 days of culture. As highlighted above, these ihGDF-5 concentration
levels did not stimulate sustained impacts on hBM-MSCs gene expression in 2D monolayer culture
(see Figure 1a,c).
Figure 3. Poly-lactic-co-glycolic-acid (PLGA) transient carriers field emission-scanning electron
microscopy (FE-SEM) image, particle size distribution, and ihGDF-5 release profile. FE-SEM images
indicated spherical morphology of carriers (a); the size distribution set at 230± 80 nm their mean size (b).
Release profiles performed in vitro at 37 ◦C indicated a ihGDF-5 mean concentration of 1.6 ng/mL/day
released from the 100 mg of PLGA-NCs loaded within HY-FIB over 11 days of culture (c).
Therefore, by excluding any non-specific ihGDF-5 induction (released within the 3D scaffold by
the NCs), we could now observe cell behaviors arising from the HY-FIB microenvironment in both
static and dynamic conditions.
3.3. hBM-MSCs Cultivation in HY-FIB 3D Microenvironment
The HY-FIB assembly featured a braided band (3 × 10cm) joined to a fibrin hydrogel (on a band
surface of 6 cm2) containing 8 × 105 hBM-MSCs and 100 mg of ihGDF-5/PLGA-NCs. The picture
and schematic representation of the 3D system is shown (Figure 4a,b). Field Emission Scanning Electron
Microscopy (FE-SEM) images of the scaffold illustrate hyaluronate fibers, embedded within a fibrin
hydrogel (Figure 4c), which provided an entrapment surface for both NCs and hBM-MSCs (Figure 4d).
HY-FIB was exposed to 10% deformation over a 1 Hz frequency for 4 h a day during the dynamic
culture experiments via a cyclic strain bioreactor, illustrated in Figure 4e [24]. In greater detail, a HY-FIB
braided band was held at one end by a motionless arm and at the other end by a sliding one. Motion was
driven by a linear motor and transmitted through the braided band to cells embedded within the fibrin
hydrogel. The motionless arm comprises a base, attached to the side wall of the culture chamber,
Cells 2020, 9, 1268 10 of 21
housing the electronic components for load monitoring, and from which extended a cantilevered
shelf whose deformation is measured by four strain gauges. The whole system was housed within
an incubator to ensure the appropriate CO2 gaseous environment to control the pH of the cell culture
media and 37 ◦C operational temperature.
Figure 4. HY-FIB three-dimensional (3D) scaffold features and cyclic strain bioreactor. Schematic
HY-FIB representation (a) and image of 3D scaffold (b). SEM images of hyaluronate braided fibers
(10 µm mean diameter size) (c) joined to a fibrin web which entrapped both NCs and hBM-MSCs (d).
Cyclic strain bioreactor (e) and in-silico study of stress distribution over HY-FIB upon mechanical
strain of 10% (f). The simulation involved only the stress of the fibrin 3D environment, neglecting any
further contribution.
The stress delivered to the cells immobilized within the system was explored via computational
analysis that estimated a mean shear stress value estimated at 9 × 10−2 Pa within the fibrin 3D
environment (Figure 4f). This order of magnitude of stress value was reported for tenogenic
induction [30]; larger deformation for longer times were excluded to focus the study on 3D
environment assembled.
HY-FIB samples were collected at Day 1, 2, 5, and 11 to monitor tenogenic and cytokine marker
expression. Time points at Day 1 and Day 2 were added for 3D culture to monitor the effect of HY-FIB
on cells behavior alone or in combination with cyclic strain culture. Indeed, in static conditions
COL1A1 and DCN both displayed significant upregulation of 3.8 fold (COL1A1) and 2.6-fold (DCN)
at Days 1 and 2 before dropping progressively to elevated but non-significant levels (Figure 5a
and Figure S1 in Supplementary Materials), confirming an HY-FIB effect on this gene expression
in the first days of culture. In dynamic conditions, COL1A1 levels displayed responses similar to
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the static culture in the first two days but progressively rising thereafter to significant levels (2.9 fold)
at Day 11, probably due to strain input. DCN expression levels in response to dynamic culture
were to be elevated throughout, achieving significance at Day 11 (3-fold) (Figure 5b and Figure S1 of
Supplementary Materials).
Figure 5. Gene expression profiles of tenogenic markers and pro-inflammatory and anti-inflammatory
cytokines from hBM-MSCs within HY-FIB environment in static (a,c) and dynamic culture (b,d) up to 11
days. Days 1, 2, 5, and 11 were selected as time points to study the mRNA levels of positive tenogenic
markers (COL1A1, DCN, SCX-A, and TNMD), negative ones (COL3A1) and pro-inflammatory (IL-6,
TNF, IL-12A and IL-1β) and anti-inflammatory (IL-10 and TGF-β1) cytokines. Effect of HY-FIB
environment on cells behavior was visible along the first two days of culture; a better over expression
of tenogenic markers and anti-inflammatory cytokines was observed in dynamic culture at Day 11.
hBM-MSCs within HY-FIB at time zero were used as control. * <0.05; ** <0.01; *** <0.005; **** <0.001.
N = 3 (biological replicates); n = 3 (technical replicates).
SCX-A displayed significant upregulation (~340-fold) in both static and dynamic conditions at Day
1, suggesting an effect of HY-FIB system, on this gene expression. SCX-A levels were substantially
elevated in both static and dynamic condition at all following time points studied, even if a larger
and significant increase was observed in dynamic condition; an increase of 800-fold in static and of
1600-fold in dynamic culture conditions was monitored at Day 11 (Figure 5a,b and Figure S1 of
Supplementary Materials). Tenomodulin gene expression was also tested by RT-qPCR, but no
expression was detected, probably because it is an event occurring during late differentiation [65].
Sustained, significant, downregulation of COL3A1 was observed in either static or dynamic conditions
which instead either decreased progressively (static) or decreased through to Day 5 before reestablishing
Day 0 levels at Day 11 (dynamic).
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The data suggested an overall effect of the 3D environment on cells behavior clearly visible
along the first two days of culture; furthermore, a statistically significant COL1A1, DCN, and SCX-A
over-expression was observed after 11 days when mechanical strain was provided (Figure S1 in
Supplementary Materials).
Cytokine transcript expression data is illustrated in Figure 5c,d, for static and dynamic culture,
respectively. HY-FIB system has an effect also on cytokines gene expression, as observed in all time
points monitored with respect to Day 0, within static culture. Indeed, pro-inflammatory cytokines IL-6
(~6-fold), TNF (~10-fold), IL-12A (≤600-fold), and IL-1β (~200-fold) displayed rapid and significant
upregulation that was maintained for the entirety of the experimental duration. Anti-inflammatory
TGF-β1 on the other hand displayed either no change (Day 11) or significant down-regulation
(other time points) while IL-10 exhibited an overall similar profile to Il-1β culminating in marked
upregulation at day 11 (~300-fold) (Figure 5c).
Dynamic culture conditions had a distinct and significant effect on IL-6 with expression levels
achieving a peak upregulation of 1.5-fold at Day 1 and decreasing to undetectable levels by Day 11
(Figure S2 in Supplementary Materials). TNF and IL-1β were both gradually upregulated before
achieving ~200-fold and ~300-fold, respectively, upregulations at day 11 (compared to 10-fold
and 100-fold in static conditions). IL-12 displayed a similar profile of upregulation in dynamic vs. static
culture conditions while achieving maximal levels that were 3X less in dynamic. Anti-inflammatory
IL-10 expression levels were consistent across both dynamic and static conditions. In contrast to static
culture, TGF-β1 was significantly downregulated until day 5, and it underwent a 5-fold increase at Day
11 in dynamic culture conditions (Figure 5d and Figure S2 in Supplementary Materials).
Histological characterization of HY-FIB scaffold in both static and dynamic culture at Days 5
and 11 are reported in Figure 6; the overall scaffold structure was stained with Sirius Red for collagen
highlighting. Despite fibrin hydrogel matrix, collected at Day 0, was only light pink stained, the same
matrix was clearly stained in red at Day 5 and 11 in both samples taken from static and dynamic
culture. However, a less homogeneous matrix organization and staining was observed in the samples
taken from static culture. This data is in agreement with gene expression indications and confirmed
that both HY-FIB alone and HY-FIB plus cyclic strain had an effect on cells phenotype commitment.
Figure 6. Histology characterization of the overall HY-FIB scaffold structure with Sirius Red staining.
HY-FIB scaffolds in both static and dynamic culture at Days 5 and 11 are reported; the overall scaffold
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structure was stained with Sirius Red for collagen highlighting. Fibrin hydrogel was light pink stained
in the sample collected at Day 0. Fibrin matrix was clearly stained in red at Day 5 and 11 in both
samples from static and dynamic culture. Less homogeneous scaffold matrix structure and staining
was observed in samples taken from static culture.
The expression of type 1 Collagen, a tenogenic matrix-associated marker, was monitored by
immunofluorescence over the culture time (see Figure 7). At day 1, empty areas surrounding the cells
are present, probably due to absence of uniform fibrin hydrogel. These spaces were then progressively
filled with the protein, presumably via secretion into the extracellular environment. The level of
staining observed under static conditions decreased after Day 1 and was maintained at ~50% of original
levels thereafter while levels were maintained consistent to Day 0 in dynamic culture. Moreover,
in the dynamic condition a more uniform cells distribution was noted throughout the hydrogel matrix,
especially at day 11.
Figure 7. IF and quantitative-IF assays of type 1 Collagen (COL1A1) in 3D static and dynamic2 culture
of hBM-MSCs for 11 days. At day 1, holes within the hydrogel structure are evident nearby cells
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surroundings. These areas were progressively filled by COL1A1 protein (stained in green) and it
happened more uniformly during the dynamic cultivation (see day 11). Fluorescence quantification by
ImageJ software, reported in the plot, confirmed the presence of more abundant signal (0.2–0.3 fold
changes) in dynamic condition; signal intensity in each time point was normalized by cell number
(e.g., by amount of cell nuclei revealed by DAPI staining). * ≤0.05; ** <0.01. N = 3 (biological replicates);
n = 3 (technical replicates).
4. Discussion
The HY-FIB system is engineered to support delivery of PLGA nanocarriers (PLGA-NCs) within
the hydrogel matrix, enabling controlled delivery of specific molecules within 3D environment,
e.g., drugs or other biological signals. The active form of hGDF-5 loaded into PLGA-NCs for controlled
delivery within HY-FIB environment was investigated in a previous study [53]. Here, we investigated
the effect of the HY-FIB 3D environment (hyaluronate band + PLGA carriers + fibrin gel) on hBM-MSCs
tenogenic and cytokine marker gene expression in both static and dynamic, mechanical, input scenarios.
We adopted the previous HY-FIB configuration including PLGA-NCs, but on this occasion, we delivered
an inactive form of hGDF5. In this manner, the biochemical input provided by the growth factor was
excluded, but the complete HY-FIB configuration was maintained, and we were thus able to investigate
the impact of mechanical input alone.
HY-FIB braided fibers enabled a defined mechanical stimulation of 9 × 10−2 Pa provided to
hBM-MSCs during the 4h/day dynamic culture regime. The mean shear stress was calculated by FEM
modeling [62], assuming a system homogeneous behavior at a density of 1050 kg/m3 and Young’s
modulus of 4.56 Mpa [53]. A Poisson ratio value of 0.25 was adopted as described elsewhere [62]. Further
mechanical inputs with different intensities and durations were not investigated, not being the aim of
the present work. Stress values resembling reduced physiological activity, similar that the ones used
here, have been reported to direct stem cell commitment to a tenogenic phenotype [31,36,66].
COL1A1 is the major component of tendon tissue (75–85% of the dry mass of tendon), and is
responsible for its mechanical strength [64]. In the static group, COL1A1 showed a≥3-fold upregulation
during the first and second day of cultivation. These data seem to suggest an overall effect of the 3D
environment on cells behavior. COL1A1 expression was progressively reduced to a 2-fold upregulation
at Day 11, in static environment. In dynamic conditions, its mRNA levels showed similar behavior
during the first two days of cultivation (an increase up to 3-fold-changes, then reduced at Day 2).
However, its expression was subsequently increased again to 2.8-fold at Day 11. Decorin (DCN),
a small leucine-rich proteoglycan implicated in the regulation of fibrillogenesis, is a fundamental
component of the tendon extracellular matrix (ECM) [67]. Compared to the static condition, a significant
enhancement, up to 2.5-fold, of the mRNA level of DCN was shown when hBM-MSCs were cultured
for 11 days with mechanical stimulation.
Scleraxis-A (SCX-A) is a neotendon marker, expressed in pro-tendon sites in the developing
embryo. Specifically, SCX-A is a tendon-specific basic helix-loop-helix transcription factor responsible
for the transition of MSCs into tendon progenitors [68]. We observed substantial increases in SCX-A
expression, up to 800-fold in static and 1600-fold in dynamic conditions after 11 days, demonstrating
a stimulatory effect via the 3D system organization and consistent with previous observations [69–71].
COL3A1 mRNA level seems to be downregulated after 2 days in the static group and after 5
days in the dynamic group. Its downregulation can be considered a positive indication of proper cell
differentiation; indeed, it seems that COL3A1 is the main responsible of fibrotic and scarred tissue
arrangement and has been consistently reported at the rupture site of human tendons. [64].
From both histology and immunofluorescence assays, we noted that the area surrounding the cells
was progressively filled by type 1 Collagen and, at Day 11, the extracellular matrix seemed to undergo
remodeling (Figures 6 and 7). Moreover, in dynamic conditions a more homogeneous cell distribution
within the hydrogel matrix was observed in the IF images. These findings support the concept that
3D cultivation provides cues to the hBM-MSCs, and that dynamic signaling enables the adoption of
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a more uniform behavior including type 1 Collagen protein deposition in the externally available space
of the fibrin hydrogel. A near total absence of type 3 Collagen was found, except for a very small
fluorescence signal at day 1, in both static and dynamic conditions (data not shown). These data suggest
that tenogenic commitment of hBM-MSCs cultured within HY-FIB environment may be enhanced
when dynamic stretching is applied.
MSCs secrete a variety of cytokines and growth factors that promote cell recruitment, migration,
proliferation, and differentiation. MSCs are also immunomodulatory, which may allow them to exert
beneficial effects on the local immune cell population at the site of muscle injury [72]. To better
understand the hBM-MSCs inflammatory response when cultured within HY-FIB, cytokine expression
was monitored along the 11 days of culture. The balance between pro- and anti-inflammatory soluble
factors in the tendon healing process exerts a major impact on successful resolution of inflammation [73].
Recent analysis of tendinopathy biopsies showed a distinct inflammatory infiltrate in the initial phase
of tendinopathy with a high content of pro-inflammatory factors such as IL-6, TNF-α and IL-17 [74].
To exclude a role for ihGDF5 in cytokine expression induction we evaluated their expression
in hBM-MSCs undergoing 2D planar cultivation as a negative control. Indeed, in disc degeneration
models using in vitro three-dimensional cultures, human annulus cells display increased expression
of pro-inflammatory cytokines, such as IL-1β and TNF-α, while exposure to TNF-α and IL-1β
resulted in significant downregulation of GDF-5 [75]. Therefore, it is plausible that the GDF-5 may
upregulate the expression of pro-inflammatory genes in hBM-MSCs leading to the maintenance
of an autocrine feedback. However, when the ihGDF-5 was added, no statistically significant
expression of pro-inflammatory cytokines was observed; therefore, ihGDF-5 did not exert any effect on
cytokines expression.
The addition of PLGA-NCs enabled an informed analysis of the inductive role of the HY-FIB
overall structure. Previous studies have noted that cytotoxicity of SEE-fabricated PLGA-NCs on blood
mononucleate viability, monitored with MTT assay [76], was not affected after either 24 or 48 h. Here,
the overall HY-FIB system (loaded with SEE fabricated NCs) does not evidence any toxic effect on
hBM-MSC cultivated within it for 11 days, providing an indirect indication about SEE technology as
suitable process for biomedical carriers production.
In general, we observed that pro-inflammatory gene expression was higher in static than in
dynamic conditions at all-time points. On the contrary, the anti-inflammatory cytokines IL-10 was
consistently upregulated in both static and dynamic conditions; while TGF-β1 was downregulated
at all the time points tested except day 11, when, it showed a marked increase (4-fold) only in dynamic
environment. The described behavior confirmed that MSCs respond to a variety of biophysical
cues; indeed, as suggested by Qazi et al., 3D culture of MSCs on biomaterials can promote cell-cell
interactions and enhance the paracrine effects of MSCs [77]. Moreover, as concluded by Ogle et al.,
historically, biomaterial-based therapies to promote tissue regeneration were designed to minimize
the host inflammatory response. Recently, the roles that monocytes and macrophages can play in
tissue repair have been highlighted. In this context, material properties and their possibility of specific
biomolecule controlled delivery has been engineered to achieve a given biological response that can be
tuned not only to a better integration with biological systems but also in regulating the inflammatory
response [5].
The overall and statistically significant balance of pro- vs. anti-inflammatory cytokines expressed
by cells provided indications regarding the importance of dynamic culture for 3D in vitro model
systems. For instance, IL-6, a well-known pleiotropic cytokine delivered by tissues in response to
physio-pathological changes such as physical exercise, infection, and injury, was reported to deeply
alter skeletal muscle milieu, by affecting the activity and quality of cellular interactors during tissue
regeneration and leading to the fibrotic response [78]. In our 3D model system, IL-6 gene expression was
considerably reduced in hBM-MSCs that underwent dynamic 3D HY-FIB cultivation when compared
to the same cells cultivated in static condition.
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It is worth of note that there is no specific literature on cytokines response by hBM-MSCs cultivated
within 3D scaffold. Almost all published studies described cell-specific differentiation toward a given
phenotype, without considering how cytokines expression may be related to a 3D in vitro scaffold
system. In this sense, the present investigation is the first study, which suggests cytokines expression
as a further variable to monitor cell behavior and reaction when loaded into a 3D in-vitro model.
Moreover, improved balance in anti-inflammatory cytokines observed for HY-FIB plus cyclic strain may
be considered an indication of better cells response to the 3D in vitro system designed and proposed.
5. Conclusions
The 3D cell culture yielded evidence of type 1 Collagen expression observed by both
immunohistology and gene assay. When the same 3D system was cultivated under cyclic strain
stimulation, the mechanical input stimulated a statistically significant increase in tenogenic markers
expression when compared to the same cells assembled into the 3D system, but cultivated in a static culture.
Further studies may involve a deeper understanding of the relation between collagen type I production,
cell commitment and mechanical input strain percentage or duration; in this sense, HY-FIB system can
be considered a good instrument for this study. The 3D culture system activated also the expression
of pro-inflammatory cytokines, and, when cyclic strain was applied, pro-inflammatory cytokine gene
over-expression by hBM-MSCs was better balanced against over-expression of anti-inflammatory
cytokines. It remains to be determined what the involvement and the immunomodulatory activity of
hBM-MSCs are, and the role of implantable biomaterials in the stimulation of inflammatory reactions.
For instance, the stimulation of local inflammation is reported as an important event in triggering repair
in avascular tissues, such as cartilage and tendons [5].
On the other hand, the presence of PLGA-NCs within the fibrin hydrogel would allow the delivery
of specific biomolecules that may be studied for the ability to further modulate inflammation reactions
or promote regeneration/repair events. In this sense, HY-FIB provides a potential strategic approach to
address a range of issues via the provision of a tightly controlled in vitro protocol. The 3D scaffold is
a potential system to organize the sustained release of different biochemical signals and opens concrete
perspectives for developing 3D bioengineered models to understand specific molecular and cellular
composition of damaged systems.
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